![]() |
||||
MATra Examples and Applications |
||||
References
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
| Fluorescent | Phase contrast |
![]() |
![]() |
"After having tested MATra in a variety of experimental set ups we can summarize the following advantages:
Dr. Oliver Gires, LMU Munich, Germany |
Neurosciences are a vast and expanding field of research focussing on highly sophisticated and enthralling questions. With Magnet Assisted Transfection IBA offers a very gentle and potent tool for the transfection of many kinds of neuronal cells. Magnet Assisted Transfection is the ideal solution to overcome problems related to the study of complex and easily interrupted systems.
Transfection of primary cortical neurons |
|
| Example 1 | |
![]() |
![]() |
Embryonic cortical neurons were transfected with human NCAM. After transfection membrane-localized NCAM (not endocytosed) was detected using a Cy3-coupled secondary antibody (red). Afterwards, the internalised, endocytosed NCAM was stained by a Cy2-coupled secondary antibody (green, see arrows) in the cell soma (left) and in axonal vesicles (right). |
|
Example 2 |
|
![]() |
![]() |
| Primary cortical neurons from mice embryonic day 15.5 (E15.5) were grown on poly-L-lysine coated coverslips at a density of 800.000 cells/well in a 24-well plate. The neurons were transfected after 1 day in vitro (DIV 1) with pCX-EGFP-N1 plasmid. Transfection was carried out as recommended by the manufacturer (0.6 µg DNA, 0.6 µL Matra-A reagent). Cells were fixed 24 h later (DIV 2) and GFP fluorescence was visualized using a confocal laser scanning microscope. |
|
| "With MATra we achieved a higher transfection efficiency than with different liposomal transfection methods and no toxicity to the cells was observed." Dr. Simone Diestel, Institute of Animal Science, University Bonn, Germany |
![]() |
Cells maintain their endogenous expression pattern and stay unaffected from transfection related influences: B103 neuroblastoma cells were plated at 105 cells/well in Dulbecco’s modified Eagle’s medium + 10% fetal calf serum on poly-L-ornithine-coated glass coverslips in 24-well plates (Corning Life Sciences, Lowell, MA) and transfected using 0.2–0.8 μg of plasmid DNA per well and MATra-A beads on a 24 Magnet Bar Plate. The medium was changed 1–2 hrs after transfection, and expression was allowed to proceed for a further 16–24 hrs. Figure: Investigation of APP dimerization using APP-GFP. A, confocal image of a B103 cell expressing APP-GFP. B–G, wide-field images of B103 cells expressing APP-GFP alone (B–D) or in combination with APP-mCherry (E–G). B and E, GFP channel. C and F, mCherry channel. D and G, GFP lifetime. Scale bars: 10 μm. H, histograms of FRET efficiencies in different experimental conditions. PDF, probability density function. Expression levels were high enough to aquire fluorescence lifetime images (Fig. B-G), which permitted calculating the levels of interaction between APP-GFP molecules in the cell (Fig. H) Data kindly provided by Dr. Matthias Gralle, Max-Planck-Institute for Evolutionary Anthropology, Leipzig, Germany, Gralle et al. (2009) J Biol Chem 284, 15016-25. |
| "Several liposomal methods were tried out, but the transfection efficiency was low, and the transfected cells were rounded and visibly unhealthy. With MATra, the expression pattern of APP-GFP was indistinguishable from the known expression pattern of endogenous APP, and the cells maintained the typical elongated morphology with protrusions", said Dr. Gralle at MPI, Leipzig, Germany. |
Cerebellar granular cells from CD1 mice
![]() |
Cultured cerebellar granular cells from CD1 mice were transfected by below 4 constructs (A-D) using MATra-A. See application note and reference article “Renker et al. MATra- ein Trojanisches Pferd für eine zellschonende Transfektion, BIOSpektrum 2010“(pdf, 1819 kb) |
Primary hippocampal neurons (E14) were grown on 15 mm glass coverslips on a 12 well at density of 150.000/cm². The neurons were transfected 4 d.i.v. with pSyn-eGFP using 25 µl MATra complex per well (prepared by adding a MATra-A Reagent-DNA complex mixture (2.8 µg cDNA; 2.8 µl beads) into 175 µl neuronal medium without serum). The cells were fixed 6 d.i.v. with 4% PFA and imaged.| "With MATra we can transfect and modulate the expression levels of exogenous proteins in highly sensitive primary neurons without any toxicity. Once optimized, double and even triple transfections with different DNA ratios are easily achieved", said Dr. Mika Ruonala, Center for Membrane Proteomics, University of Frankfurt. |
(Data kindly provided by Dr. Mika Ruonala, Center for Membrane Proteomics, University of Frankfurt, Germany;
ruonala@em.uni-frankfurt.de)
Dahl, TB and Ranheim T Institute of Internal Medicine, Oslo University Hospital Rikshospitalet.
GFP expression in THP1 cells after transient transfection with pCMV-ASC-GFP DNA (Origene). THP1 cells (1, 0.5 or 0.25 x 106 cells per well in a 12 well plate) were immobilized on collagen coated plates (BD) for 24h. The cells were transfected with 1.5 µg DNA expression plasmid using MATra-A (1 µl/1 µg DNA) or Lipofectamine and MA Lipofection enhancer. GFP fluorescence was detected by flow cytometry after 22 hours.
Transfection efficiency was increased in cells transfected with MatraA compared to cells transfected with Lipofectamine and had an optimal cell density between 0.5x106 and 0.25x106 (table 1). Figure 1 demonstrates a representative histogram of cells seeded with a density of 0.5x106 and transfected with MatraA
| Cell density | Lipofectamine | MatraA |
| 1x106 | 2.5 | 20.2 |
| 0.5x106 | 4.5 | 26.3 |
| 0.25x106 | 4.4 | 17.4 |
| Table 1. Transfection efficiency (%) according to cell density and transfection method (n=2) | ||
![]() |
||
Figure 1. Cell sample with density of 0.5x106 and transfected with MatraA (dotted line) compared to untransfected cells (full line). Transfection efficiency 28% |
||
![]() |
![]() |
Densitometric analysis of immunoblot data. Data for Jun expression were normalised to protein levels. Data show optimal expression using each transfection reagent, where ‘Con’ represents average ‘empty vector’ controls given a value of 1. |
Optimisation of c-jun over-expression in primary human chondrocytes
Method. Primary human articular chondrocytes isolated from cartilage of patients undergoing total knee replacement were cultured for approximately 10 d before trypsinisation and re-seeding into 6-well dishes at approx. 70% confluence. Cells were transfected with pCMV2 harbouring human c-jun or empty vector using either FuGENE HD or MATra-A transfection reagents, using protocols and a range of DNA:reagent ratios as suggested by manufacturers. After 24 h cells were lysed and 10 μg lysates subjected to SDS-PAGE and immunoblotting using α-Jun antibody (Santa Cruz).
| "Our study of the molecular processes underlying cartilage degradation in arthritis has sometimes been hampered by poor transfection efficiency of primary human chondrocytes, despite our trialling a variety of liposomal transfection reagents. The increased efficiencies we have observed using MATra promises to expand the range of experiments we can attempt, significantly facilitating our research." Gary Litherland, Musculoskeletal Research Group, Institute of Cellular Medicine, Newcastle University, Newcastle, UK |
| "We have used MATra-A as an alternative to electroporation for Sf9 insect cell transfection with Baculovirus and have been excited about the performance: The MATra approach is extremely gentle and does not cause the cell death we often observe with the harsh electroporation procedures. Therefore, we now routinely use the MATra system for insect cell transfection." Dr. Rudolf Hauptmann, Boehringer Ingelheim RCV GmbH & Co KG, Austria |
80% down-regulation of the protein!
Human umbilical vein endothelial cells (HUVEC) were efficiently transfected with short interfering RNA (siRNA) using magnet assisted transfection. Briefly, 3 µg of siRNA were diluted in OPTIMEM I medium to give a final volume of 200 μl for each well to be transfected (final concentration approximately 30 nM). For the formation of the transfection complex, 3 μl of MATra-si reagent were added to the diluted siRNA, carefully mixed and allowed to incubate at room temperature for 25 minutes. HUVEC were once washed in OPTIMEM I, the medium was discarded and then fresh OPTIMEM I (2 ml per well) was added to the cells. The siRNA/magnetic beads were then overlaid drop wise onto the cells (200 μl/well). Cells were incubated with the transfection complex on a custom made magnetic plate which was specifically designed to fit the wells of Flexcell plates (Universal Magnet Plate, IBA) for 15 minutes in the cell incubator to allow beads to penetrate the target cells. Thereafter, to induce rapid zyxin turn over, cells were shortly exposed to cyclic stretch (30 minutes, 0.5 Hz, 10 % elongation1). After this manoeuvre, the medium was changed to prevent cytotoxic effects from the transfection reagent, and the cells were kept further under their normal culture conditions. Gene silencing was optimal 72 hours after transfection.
Other gene products knocked down with similar efficiencies: Ku70/Ku80, PARP1, hnRNP U.
|
|||
|
|||
![]() |
![]() |
||
Figure above: Zyxin knock down by Magnet Assisted Transfection (MATra). Immunofluorescence analysis of HUVEC. Representative confocal immunofluorescence images of zyxin (Cy3/red) in non-transfected human cultured endothelial cells (HUVEC; left picture) and HUVEC after Magnet Assisted Transfection (as described in the text; right picture). The cells were counter-stained with the focal adhesion protein paxillin (Cy2/green) and the DNA-binding nuclear dye DAPI (blue). Paxillin co-localizes with zyxin exclusively in the focal adhesions (yellow) but not in the stress fibers or in the nucleus. |
|||
![]() |
|||
| "We have tried to efficiently transfect siRNA into Huvec for month with only minor success (up to 8% efficiency). With Magnet Assisted Transfection using the MATra reagent we finally achieved a knock down of 80% – definitely a break through." PD Dr. Marco Cattaruzza, Institute for Physiology and Pathophysiology, Heidelberg University, Germany |
BeWo cells were efficiently transfected with an expression vector coding for green fluorescent protein (GFP) using magnet assisted transfection.
Therefore, BeWo cells were seeded 24 h before transfection in a 12well plate at a density of 180 000 cells/well. 1µg, 2µg and 3µg of plasmid respectively were incubated in 200µl OptiMEM® I Reduced Serum Medium with Lipofectamine in a ratio of 1:3 for15 minutes. MA Lipofection Enhancer reagent was added in a ratio 1: 1.2 with an additional incubation time of 15 minutes. The plate was placed on the MATra Magnet Plate for 15 minutes at room temperature to allow beads to penetrate the target cells. GFP fluorescence was detected by flow cytometry after 36 hours.
(Data kindly provided by Andrea Milenkovic, Human Genetics Regensburg, Germany)
1.![]() |
2.![]() |
3.![]() |
4.![]() |
|
|
| Tranfection efficiency % | |
| Lipofectamine | < 1 |
| Lipofectamine+Enhancer 1µg Plasmid | 13.8 |
| Lipofectamine+Enhancer 2µg Plasmid | 21.2 |
| Lipofectamine+Enhancer 3µg Plasmid | 35.3 |
![]() |
![]() |
![]() |
| Phase contrast | GFP fluorescence | Overlay |
![]() |
![]() |
![]() |
![]() |
| With MATra transfection efficiency has been increased 8x compared to lipofection. |
![]() |
![]() |
| MATra-A | Competitive lipofection reagent |
Hepatocytes prepared from liver were seeded on 3.5 cm diameter dishes (3-5x105 cells/dish) and allowed to grow overnight. The cells were transfected with pCMV-LacZ, a CMV enhancer/promoter-driven β-galactosidase plasmid, as described in the standard protocols for MATra. The cells were fixed with 1% glutaraldehyde and stained in 2 mg/ml X-Gal solution. β-galactosidase-expressing blue cells were examined by microscopy.
| Luciferase activity | Conditions | |
| A | 1 | 3 µl of Lipofection Reagent "F6"/500 ng GAL-LUC and 50 ng CMV-GAL |
| B | 7.59 | like A, plus 1 µl of MA Lipofection Enhancer |
| C | 64.75 | like B, but 2500 ng GAL-LUC and 250 ng CMV-GAL |
| HeLa | ![]() |
![]() |
|
| CHO-K1 | ![]() |
||
| Standard transfection method | Magnet Assisted Transfection | For indicated cells the following methods were tested. 1: Calcium phosphate vs Magnet Assisted Lipofection, 2-4 Lipofection vs Magnet Assisted Lipofection, 5: Lipofection vs Magnet Assisted Transfection. Data kindly provided by industrial IBA customer. |
|
| Data kindly provided by Dr. Günther Keil, Friedrich-Loeffler-Institute, Federal Research Institute for Animal Health, Island Riems, Germany. |
|||
| contact | how to order | download/tech info | patents/licenses | jobs | search | site map | IBA web shop |